Navigation Links
Genomic in Medical Technology

Ipsogen Reports Incorporation of the Genomic Grade in the 2009 St. Gallen International Consensus Meeting on the Primary Treatment of Early Breast Cancer

... Cancer indicated for the first time that the genomic Grade could be considered as an adjunct to ... is provided by proliferation. MapQuantTM genomic Grade is available to European oncologists and pathologists. The genomic grade test analyzes a set of 97 genes to ...

Genomic Health Study Shows Breast Cancers in Men Display Very Similar Gene Signatures to Those in Women

... - Largest genomic Study Comparing Gene Expression in Female and ... ORLANDO, Fla., May 29 /PRNewswire-FirstCall/ -- genomic Health, Inc. (Nasdaq: GHDX ) today announced ... investigator of the study. "This is the largest genomic study to compare gene expression in female and ...

Siemens Corporate Research Develops RAPID2 System for Fast Discovery of Discriminative Pathogen Signatures

... of information technology with today's improved genomic sequencing to quickly identify genomic signatures unique to the set of organisms to be ... quickly identifying new biomarkers based on the genomic sequence of a particular pathogen," says Dr. ...

SeqWright's Clinical Trial Support Contributes to the Approval of Two HPV Diagnostic Systems

... an international leader in the field of contract genomic services, announced today its involvement in ... SeqWright Incorporated is a world-class genomic services support organization based in Houston, ... in state of the art Molecular Biology and genomic services within a highly regulated GLP/CLIA ...

Research Teams at J. Craig Venter Institute and Ludwig Institute for Cancer Research Uncover New Chromosomal Alterations in Cancer Using Transcriptome Sequencing Approach

... for Cancer Research (LICR) have uncovered new genomic alterations that lead to gene fusions in a breast ... known that cancers arise from various types of genomic changes in certain cells. Continued advances and ... line seemed to be very involved in some of the genomic rearrangements. This data confirms earlier ...

Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing

... to find out if participating in personal genomic testing will improve health by motivating people ... longitudinally. A complete database of genomic and clinical information will be assembled at the Scripps genomic Medicine program. "We stand upon the threshold ...

Genomic Health Announces Data Supporting Use of Oncotype DX(R) to Accurately Assess HER2 Gene Expression in Breast Cancer Patients

... CITY, Calif., Sept. 6 /PRNewswire-FirstCall/ -- genomic Health, Inc. (Nasdaq: GHDX ) today announced ... said Steven Shak, M.D., chief medical officer of genomic Health. "Based on this research demonstrating the ... The first study (Abstract 13), conducted by genomic Health and collaborators from the Eastern ...

Genomic Health Announces Results of Initial Studies to Develop Predictive Tests for Targeted Therapies

... CITY, Calif., May 31 /PRNewswire-FirstCall/ -- genomic Health, Inc. (Nasdaq: GHDX ), provider of the ... breast cancer. Oncotype DX is the first and only genomic test that predicts the likelihood of ... said Steven Shak, M.D., chief medical officer of genomic Health. "We believe this is an important step ...

Ipsogen Announces Three Studies at the American Society of Clinical Oncology (ASCO) Meeting Extending the Utility of the Genomic Grade Index for Predicting Response to Chemotherapy in Breast Cancer

... will present the results of two studies on the genomic Grade index (GGi) at the ASCO Annual Meeting, ... 30 to June 3, 2008. The data indicate that the genomic Grade index predicts response to chemotherapy ... of the GGi to inflammatory breast cancer. The genomic Grade index (GGi) is a 97-gene measure of tumor ...

New Gene Discovery Suggests Which Patients CTI's Brostallicin May Benefit

... and correlated with specific genomic information derived from the cell line panel. The ... mining strategy was used to identify the genomic and functional consequences of ... of DNA repair." In addition to correlative genomic analyses on the NCI-60 cell line panel, ...

Genomic Health Announces Identification of Genes Associated With Colon Cancer Recurrence Across Multiple Studies

... CITY, Calif., Jan. 28 /PRNewswire-FirstCall/ -- genomic Health, Inc. (Nasdaq: GHDX ) today announced the ... gene expression using methods developed by genomic Health can identify genes that may predict the ... said Steven Shak, M.D., chief medical officer of genomic Health. "This marks an important step in our ...

Multiple Studies Presented at San Antonio Breast Cancer Symposium Reinforce Clinical Utility of Oncotype DX(R)

... CITY, Calif., Dec. 17 /PRNewswire-FirstCall/ -- genomic Health, Inc. (Nasdaq: GHDX ) today announced ... expression. Based on these and other results, genomic Health plans to provide individual estrogen ... recurrence. * Finally, a study presented by genomic Health on Friday, December 14 reported gene ...

Genomic Health Announces Eight Oncotype DX(R) Studies to Be Presented at 30th Annual San Antonio Breast Cancer Symposium

... CITY, Calif., Dec. 7 /PRNewswire-FirstCall/ -- genomic Health, Inc. (Nasdaq: GHDX ) today announced ... visit http://www.oncotypedx.com . About genomic Health genomic Health, Inc. (Nasdaq: GHDX ) is a life science ...

Microarray Sequence Capture Speeds Large-Scale Resequencing of Targeted Genomic Regions

... and accurate enrichment of thousands of selected genomic regions, either contiguous or dispersed, such as ... The study, entitled "Direct Selection of Human genomic Loci by Microarray Hybridization," appears online ... human exome. Resequencing of genes or other genomic regions of interest is a key step in detecting ...

Genomic Health Announces Preliminary Results From a Study of Oncotype DX(TM) in Node-Positive Breast Cancer Patients

... CITY, Calif., Oct. 11 /PRNewswire-FirstCall/ -- genomic Health, Inc. (Nasdaq: GHDX ) today announced ... positive, node-positive breast cancer. SWOG and genomic Health plan to submit these data for presentation ... please visit http://www.oncotypedx.com . About genomic Health ...

Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog

... all been manufactured utilizing SDI's proprietary genomic Antibody Technology(TM) and will carry ... for catalog reagents." Strategic Diagnostics' genomic Antibody Technology(TM) (GAT) platform genomic Antibody Technology(TM) is a proprietary ...

Sirius Genomics Announces New Collaboration with Assistance Publique-Hopitaux de Paris

... agreement with the Assistance Publique-Hopitaux de Paris (AP-HP) to study genomic correlations in severe sepsis patients. The agreement focuses on the ... research effort because working with Sirius Genomics will help translate genomic biomarker research in sepsis from the lab bench to the patient bedside," ...

Trubion Announces Positive Data From a Phase 1 / 2 Study of TRU-016 for the Treatment of Chronic Lymphocytic Leukemia (CLL)

... of low doses of TRU-016 in heavily pre-treated patients with high-risk genomic factors and relapsed or refractory chronic lymphocytic leukemia (CLL). ... a combination regimen. Of the 24 patients with genetic data, 17 had high genomic risk factors, such as deletion of the 17p or 11q chromosomes. At the time ...

First Jatropha Genome Completed by Synthetic Genomics Inc. and Asiatic Centre for Genome Technology

... exploring the microbial life around the jatropha tree using environmental genomic techniques to sequence and analyze jatropha's root, soil and leaf ... for disease control, leading to healthier and more productive crops. These genomic solutions also allow for more efficient land usage with improved ...

Agendia's MammaPrint(R) Predicts Response to Neoadjuvant Chemotherapy in Breast Cancer

... and speak to the confidence physicians express in this state-of-the-art genomic breast cancer test," commented Dr. Richard Bender, Chief Medical Officer ... cancer treatments. The company markets four products, with several new genomic tests under development. In addition, Agendia collaborates with ...

Ipsogen Launches a New Test to Determine Tumor HER2 Status and Guide Herceptin(R) Prescription in Breast Cancer

... second test to be developped on our MapQuant Dx(TM) platform, after the genomic Grade launched by Ipsogen earlier this year. Thanks to our experience in ... is available for diagnostic use in Europe together with MapQuant Dx(TM) genomic Grade test through MapQuant Dx(TM) platform. It includes : - Easy ...

J. Craig Venter, Ph.D. Receives Double Helix Medal from Cold Spring Harbor Laboratory

... information technology, high-throughput DNA sequencing, genomic and environmental policy research, and public education in science and science policy. The legacy organizations of the JCVI are: The Institute for genomic Research (TIGR), The Center for the Advancement of Genomics (TCAG), the ...

Rubicon Provides Genome Amplification for the Cancer Genome Atlas Project

... Expansion of genomic DNA from Multiple Cancer Populations Facilitates ... Project and other systematic sequencing efforts by combining world- class genomic research, bioinformatics, and diagnostic technologies in the fight against ...

Resveratrol Longevity Science Makes Dramatic U-Turn, But Resveratrol Supplements Remain Unchanged

... for matrix of other small molecules), exerted a 9-fold greater genomic effect than plain resveratrol or a calorie-restricted diet. In this study, ... Only messenger RNA, not Sirtuin1 gene protein, was measured in this genomic test. Longevinex(R) was formulated as an emulsified, stabilized, ...

febit and TGen Collaborate to Study New DNA Capture Method

... services, febit is the only company that puts the control of simplified genomic research in the hand of the user. The seamless integration of DNA ... process. TGen's vision is of a world where an understanding of genomic variation can be rapidly translated in a manner tailored to individual ...

FDA Clears the Pathwork(R) Tissue of Origin Test for Hard-To-Identify Tumors

... The FDA's clearance underscores the growing role that patients' genomic information can play in helping physicians make better decisions. ... cancer care is the use of therapies that target specific tissues and their genomic components, rather than relying on a one-size-fits-all treatment ...

GlaxoSmithKline Collaborates with National Cancer Institute to Make Large Body of Cancer Cell Genomic Data Available to All Cancer Researchers

... cancer, GlaxoSmithKline (NYSE: GSK ) announced today the release of genomic profiling data for over 300 cancer cell lines via the National Cancer ... us to bring drugs more quickly to patients who need them." The genomic data being shared by GSK through caBIG(TM) come from cell lines derived ...

Join NPR's David Ewing Duncan, Author Jessica Queller and a Panel of Medical and Legal Experts in a 90-Minute Webcast on Genetic Testing, Genomic Medicine and Breast & Ovarian Cancer

... Conn., May 19 /PRNewswire/ -- Helix Health, the first U.S. stand-alone genomic medicine practice, is hosting a 90-minute webcast this Wednesday, May 21, 2008 from 1:00-2:30 PM EDT examining: How genomic Medicine Is Changing the Management of Breast & Ovarian Cancer To ...

Siemens and LabCorp Enter Agreement to Co-Develop New Clinical Diagnostic Tests

... new diagnostic technologies and the first in its industry to embrace genomic testing. With annual revenues of $4.1 billion in 2007, over 26,000 ... offers clinical assays ranging from routine blood analyses to HIV and genomic testing. LabCorp combines its expertise in innovative clinical testing ...

Discovery Leads to Earlier Diagnosis of Type 1 Diabetes

... that type 1 diabetes patients during the honeymoon phase create a unique genomic fingerprint. The research team used a new type of blood test that identifies inflammation associated with type 1 diabetes though a unique genomic fingerprint. Remarkably, this fingerprint is evident years prior to ...

Personalized Medicine - The Genomic Revolution in Cardiac Care

... and is one of the few centers in the world to focus on cardiovascular genomic research. Dr. McCaffrey will lead a faculty of renowned experts, in the ... achieve our mission." The symposium, titled "Personalized Medicine: The genomic Revolution in Cardiac Care," is designated for 6 AMA PRA Category 1 ...

Researchers Create First Targeted Knockout Rats Using Zinc Finger Nuclease Technology

... is a leading Life Science and High Technology company. Its biochemical and organic chemical products and kits are used in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical and other high technology ...

University of Michigan Study Shows SEQUENOM's MassARRAY Technology Identifies HPV Infections Missed by Standard Hybridization Test

... About SEQUENOM SEQUENOM is a life sciences company committed to providing the best genetic analysis products that translate the results of genomic science into solutions for molecular diagnostics, biomedical research, translational research and molecular medicine applications. As an industry ...

CEL-SCI to Present Data from Multikine Clinical Trials at National Institutes of Health (NIH), National Cancer Institute (NCI) Seminar Series

... (Oral Squamous Cell Carcinoma) during the impending Multikine Pivotal Global Phase III trial and these samples will be tested by the NIH, NCI using genomic Microarray technology, developed at the NIH, NCI laboratories. About CEL-SCI Corporation CEL-SCI Corporation is developing products that ...

deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia

... by grants LSHM-CT-2006-037761, PIAP-GA-2008-218251, and HEALTH-F2-2009-223423; The U.S. National Institutes of Health; and the National genomic Network of Germany. About deCODE deCODE is a bio-pharmaceutical company developing drugs and DNA-based tests to improve the treatment, ...

/C O R R E C T I O N -- Agendia B.V./

... profiling, the company's tests aim to help physicians more accurately tailor cancer therapy. The company markets four products, with several new genomic tests in development. Agendia collaborates with pharmaceutical companies in the development of highly effective personalized drugs in the area of ...

Agendia's Breast Cancer Recurrence Test MammaPrint Included in International St. Gallen Expert Consensus Recommendations

... profiling, the company's tests aim to help physicians more accurately tailor cancer therapy. The company markets four products, with several new genomic tests in development. Agendia collaborates with pharmaceutical companies in the development of highly effective personalized drugs in the area of ...

Value of Genetic Testing for Preventing Blood Clots Unproven, According to New AHRQ Study

... was requested and supported by the Office of Public Health Genomics (OPHG) at HHS' Centers for Disease Control and Prevention. The Evaluation of genomic Applications in Practice and Prevention (EGAPP) Working Group, established by OPHG in 2005, will use this evidence report and other evidence to make ...

Data From Clinical Study of bioTheranostics Molecular Diagnostic Test Presented at American Society of Clinical Oncology Annual Meeting

... bioTheranostics discovers, develops and commercializes molecular diagnostic tests for cancer patients. Leveraging its unique expertise in genomic profiling and proprietary algorithms, bioTheranostics provides innovative tests to the oncology community that help drive personalized treatment. The ...

Swine Flu (H1N1) Infectivity to Increase Markedly and Lethality to Remain Low According to Latest Replikin* Peptide Genomic Data

... course the Swine Flu epidemic will take, Boston-based biotech firm Replikins Ltd. ( www.replikins.com ) last week analyzed the most recent peptide genomic sequence data available and determined that the infectivity of the H1N1 virus will increase markedly, while its lethality will remain relatively low ...
Other Contents
(Date:10/16/2014)... efficiently, they are anything but sustainable: environmental damage ... is becoming increasingly evident. Despite their disadvantages, however, ... regarded as the sole possibility of achieving higher ... Bernhard Schmid, an ecology professor at the University ... agriculture and forestry. After all, a new study ...
(Date:10/15/2014)... Oct. 15, 2014 Sandata Technologies, LLC, ... and community-based care, today announced it released a ... Santrax® Electronic Visit Verification™ Solution (EVV™)  for Quality ... home health company founded in 1996 and has ... The study details the challenges ...
(Date:10/15/2014)... an unexpected extent. The outbreak does not follow the ... a new disease dynamic in regions, where it has ... National Academy of Sciences Leopoldina, acatech – the German ... the German Academies of Sciences and Humanities have presented ... the statement the academies call for the following consequences ...
Breaking Biology News(10 mins):Plant communities produce greater yield than monocultures 2Plant communities produce greater yield than monocultures 3Sandata Announces Case Study with Quality Care Services, Inc. 2Academies call for consequences from the Ebola virus epidemic 2Academies call for consequences from the Ebola virus epidemic 3Academies call for consequences from the Ebola virus epidemic 4Academies call for consequences from the Ebola virus epidemic 5
(Date:10/22/2014)... Maureen Salamon HealthDay Reporter ... of conventional in vitro fertilization (IVF) -- the incubation of ... in a device inside the vagina, new research suggests. ... device, called an INVOcell, might sharply cut costs for pricey ... technology more accessible to those who don,t live near big-city ...
(Date:10/22/2014)... Dennis Thompson HealthDay Reporter ... was diagnosed with Ebola while working for NBC News ... leave the special isolation unit at Nebraska Medical Center in Omaha, ... hospital said Tuesday. A blood test confirmed by the U.S. ... can head home to Providence, R.I., NBC News reported ...
(Date:10/20/2014)... PA (PRWEB) October 20, 2014 Allegheny ... minimally-invasive procedure that enables physicians to repair a damaged ... The MitraClip system, developed by Abbott ... (MR), a progressive and life-threatening condition in which the ... blood to flow backward from the heart’s left ventricle ...
(Date:10/20/2014)... 2014 Women’s health specialist, Dr. Amber ... Gynecology of Columbus, Inc., A Division of MaternOhio Clinical ... more than 100,000 patients annually. Dr. Murphy will provide ... stages of a women’s life. She is accepting new ... Westerville and Dublin. , Dr. Murphy offers a wide ...
(Date:10/20/2014)... October 20, 2014 Zereana Jess-Huff, a 34-year-old ... Maryland 2014 on a platform to think outside the bra. ... uses her position to raise awareness about women’s other lady ... breast cancer. You say the color pink and everybody knows ... for a fact that it has not been won when ...
Breaking Medicine News(10 mins):Health News:Experimental Infertility Treatment Seems Effective, Cheaper 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 3Health News:Experimental Infertility Treatment Seems Effective, Cheaper 4Health News:U.S. Cameraman Treated for Ebola 'Free' of the Virus 2Health News:U.S. Cameraman Treated for Ebola 'Free' of the Virus 3Health News:Allegheny General Hospital Introduces New, Beating-Heart Procedure for Mitral Valve Repair 2Health News:Allegheny General Hospital Introduces New, Beating-Heart Procedure for Mitral Valve Repair 3Health News:OhioHealth Welcomes New Women’s Health Specialist to MaternOhio Specialists in Obstetrics & Gynecology of Columbus, Inc. 2Health News:OhioHealth Welcomes New Women’s Health Specialist to MaternOhio Specialists in Obstetrics & Gynecology of Columbus, Inc. 3Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 2Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 3
Other TagsOther Tags